Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 156

1.

High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients.

Saag M, Balu R, Phillips E, Brachman P, Martorell C, Burman W, Stancil B, Mosteller M, Brothers C, Wannamaker P, Hughes A, Sutherland-Phillips D, Mallal S, Shaefer M; Study of Hypersensitivity to Abacavir and Pharmacogenetic Evaluation Study Team.

Clin Infect Dis. 2008 Apr 1;46(7):1111-8. doi: 10.1086/529382.

PMID:
18444831
[PubMed - indexed for MEDLINE]
Free Article
2.

Refining abacavir hypersensitivity diagnoses using a structured clinical assessment and genetic testing in the Swiss HIV Cohort Study.

Rauch A, Nolan D, Thurnheer C, Fux CA, Cavassini M, Chave JP, Opravil M, Phillips E, Mallal S, Furrer H; Swiss HIV Cohort Study.

Antivir Ther. 2008;13(8):1019-28.

PMID:
19195327
[PubMed - indexed for MEDLINE]
3.

Use of patch testing for the diagnosis of abacavir-related hypersensitivity reaction in HIV patients.

Giorgini S, Martinelli C, Tognetti L, Carocci A, Giuntini R, Mastronardi V, Torricelli F, Leoncini F, Lotti T.

Dermatol Ther. 2011 Nov-Dec;24(6):591-4. doi: 10.1111/j.1529-8019.2012.01409.x.

PMID:
22515676
[PubMed - indexed for MEDLINE]
4.

Pharmacogenetics of hypersensitivity to abacavir: from PGx hypothesis to confirmation to clinical utility.

Hughes AR, Spreen WR, Mosteller M, Warren LL, Lai EH, Brothers CH, Cox C, Nelsen AJ, Hughes S, Thorborn DE, Stancil B, Hetherington SV, Burns DK, Roses AD.

Pharmacogenomics J. 2008 Dec;8(6):365-74. doi: 10.1038/tpj.2008.3. Epub 2008 Mar 11. Review.

PMID:
18332899
[PubMed - indexed for MEDLINE]
5.

Prospective epidemiological study of the prevalence of human leukocyte antigen (HLA)-B*5701 in HIV-1-infected UK subjects.

Orkin C, Sadiq ST, Rice L, Jackson F; UK EPI team.

HIV Med. 2010 Mar;11(3):187-92. doi: 10.1111/j.1468-1293.2009.00762.x. Epub 2009 Sep 24.

PMID:
19780860
[PubMed - indexed for MEDLINE]
6.

Studies on abacavir-induced hypersensitivity reaction: a successful example of translation of pharmacogenetics to personalized medicine.

Guo Y, Shi L, Hong H, Su Z, Fuscoe J, Ning B.

Sci China Life Sci. 2013 Feb;56(2):119-24. doi: 10.1007/s11427-013-4438-8. Epub 2013 Feb 8. Review. Erratum in: Sci China Life Sci. 2013 Mar;56(3):292.

PMID:
23393027
[PubMed - indexed for MEDLINE]
7.

Value of the HLA-B*5701 allele to predict abacavir hypersensitivity in Spaniards.

Rodríguez-Nóvoa S, García-Gascó P, Blanco F, González-Pardo G, Castellares C, Moreno V, Jiménez-Nácher I, González-Lahoz J, Soriano V.

AIDS Res Hum Retroviruses. 2007 Nov;23(11):1374-6. doi: 10.1089/aid.2006.0244.

PMID:
18184080
[PubMed - indexed for MEDLINE]
8.

[Prospective validation of a pharmacogenetic test: the PREDICT-1 study].

Muñoz de Benito RM, Arribas López JR.

Enferm Infecc Microbiol Clin. 2008 May;26 Suppl 6:40-4. Spanish. Erratum in: Enferm Infecc Microbiol Clin. 2008 Oct;26(8):536.

PMID:
18680695
[PubMed - indexed for MEDLINE]
9.

Abacavir hypersensitivity reaction: an update.

Hughes CA, Foisy MM, Dewhurst N, Higgins N, Robinson L, Kelly DV, Lechelt KE.

Ann Pharmacother. 2008 Mar;42(3):387-96. doi: 10.1345/aph.1K522. Epub 2008 Feb 26. Review.

PMID:
18303141
[PubMed - indexed for MEDLINE]
10.

HLA-B*5701 screening for hypersensitivity to abacavir.

Mallal S, Phillips E, Carosi G, Molina JM, Workman C, Tomazic J, Jägel-Guedes E, Rugina S, Kozyrev O, Cid JF, Hay P, Nolan D, Hughes S, Hughes A, Ryan S, Fitch N, Thorborn D, Benbow A; PREDICT-1 Study Team.

N Engl J Med. 2008 Feb 7;358(6):568-79. doi: 10.1056/NEJMoa0706135.

PMID:
18256392
[PubMed - indexed for MEDLINE]
Free Article
11.

Human leukocyte antigen (HLA) and pharmacogenetics: screening for HLA-B*57:01 among human immunodeficiency virus-positive patients from southern Alberta.

Berka N, Gill JM, Liacini A, O'Bryan T, Khan FM.

Hum Immunol. 2012 Feb;73(2):164-7. doi: 10.1016/j.humimm.2011.12.002. Epub 2011 Dec 8.

PMID:
22197535
[PubMed - indexed for MEDLINE]
12.

Successful translation of pharmacogenetics into the clinic: the abacavir example.

Phillips E, Mallal S.

Mol Diagn Ther. 2009;13(1):1-9. doi: 10.2165/01250444-200913010-00001. Review.

PMID:
19351209
[PubMed - indexed for MEDLINE]
13.

A sensitive and rapid alternative to HLA typing as a genetic screening test for abacavir hypersensitivity syndrome.

Martin AM, Krueger R, Almeida CA, Nolan D, Phillips E, Mallal S.

Pharmacogenet Genomics. 2006 May;16(5):353-7.

PMID:
16609367
[PubMed - indexed for MEDLINE]
14.

Distribution of HLA-B alleles in a Ugandan HIV-infected adult population: NORA pharmacogenetic substudy of DART.

Munderi P, Snowden WB, Walker AS, Kityo C, Mosteller M, Kabuye G, Thoofer NK, Ssali F, Gilks CF, Hughes AR; DART Trial Team.

Trop Med Int Health. 2011 Feb;16(2):200-4. doi: 10.1111/j.1365-3156.2010.02688.x. Epub 2010 Nov 23.

PMID:
21091860
[PubMed - indexed for MEDLINE]
Free Article
15.

Cost impact of prospective HLA-B*5701-screening prior to abacavir/lamivudine fixed dose combination use in Germany.

Wolf E, Blankenburg M, Bogner JR, Becker W, Gorriahn D, Mueller MC, Jaeger H, Welte R, Baudewig M, Walli R, Stoll M.

Eur J Med Res. 2010 Apr 8;15(4):145-51.

PMID:
20554495
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Economic efficiency of genetic screening to inform the use of abacavir sulfate in the treatment of HIV.

Kauf TL, Farkouh RA, Earnshaw SR, Watson ME, Maroudas P, Chambers MG.

Pharmacoeconomics. 2010;28(11):1025-39. doi: 10.2165/11535540-000000000-00000.

PMID:
20575592
[PubMed - indexed for MEDLINE]
17.

A study of HIV provider attitudes toward HLA-B 5701 testing in the United States.

Watson ME, Patel LG, Ha B, Wannamaker P, Cuffe R, Shaefer M.

AIDS Patient Care STDS. 2009 Nov;23(11):957-63. doi: 10.1089/apc.2008.0245.

PMID:
19839743
[PubMed - indexed for MEDLINE]
18.

Genetic and immune predictors for hypersensitivity syndrome to antiepileptic drugs.

Neuman MG, Cohen L, Nanau RM, Hwang PA.

Transl Res. 2012 May;159(5):397-406. doi: 10.1016/j.trsl.2012.01.004. Epub 2012 Jan 26.

PMID:
22500513
[PubMed - indexed for MEDLINE]
19.

Association of genetic variations in HLA-B region with hypersensitivity to abacavir in some, but not all, populations.

Hughes AR, Mosteller M, Bansal AT, Davies K, Haneline SA, Lai EH, Nangle K, Scott T, Spreen WR, Warren LL, Roses AD; CNA30027 Study Team; CNA30032 Study Team.

Pharmacogenomics. 2004 Mar;5(2):203-11.

PMID:
15016610
[PubMed - indexed for MEDLINE]
20.

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.

Mallal S, Nolan D, Witt C, Masel G, Martin AM, Moore C, Sayer D, Castley A, Mamotte C, Maxwell D, James I, Christiansen FT.

Lancet. 2002 Mar 2;359(9308):727-32.

PMID:
11888582
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk